Clinical Trial Update: High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for high-risk neuroblastoma under the SIOP-Europa-Neuroblastoma (SIOPEN) consortium; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: High-Risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy | Phase 3 | Status: RECRUITING